title: The Eleventh Circuit holds that agreements in which pharmaceutical companies pay generic companies not to compete may be valid.
authors.forename: Amy
authors.initials: A
authors.lastname: Garrigues
mesh_terms: D016363:Antitrust Laws; D003132:Commerce / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic / Q000191:economics*; D004465:Economic Competition / Q000191:economics / Q000331:legislation & jurisprudence*; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D014481:United States
chemical_list: D016568:Drugs, Generic